Damineh Morsali, Ph.D.


Damineh Morsali focuses on complex patent litigation. Damineh earned her Ph.D. in neuropharmacology from Oxford University, followed by postdoctoral research positions at world-renowned institutions. Her scientific research background in both clinical and experimental drug trials includes the identification of novel mechanisms of pathology and novel therapeutics for multiple sclerosis and Guillain-Barré syndrome, and gene therapy for stroke. Damineh leverages her scientific knowledge to assist clients with pre-suit investigations, patent litigation, International Trade Commission (ITC) proceedings, licensing, and due diligence analysis in an array of technologies, including biologics, RNA interference, biotechnology, pharmaceuticals, and medical devices.




  • J.D. University of Houston Law Center 2018
  • Ph.D. Neuropharmacology Oxford University 2009
    • Business Certificate, Saïd Business School, Oxford University
    • Academy of Achievement, Class of 2007
  • B.S. Molecular Genetics magna cum laude King's College, University of London 2004

Bar Admissions

  • New York

Professional Memberships and Activities

  • Former business consultant , Higher Education London Outreach, University College London